Compare AKBA & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AKBA | NUAI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.4M | 403.6M |
| IPO Year | 2014 | 2024 |
| Metric | AKBA | NUAI |
|---|---|---|
| Price | $0.95 | $5.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.67 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 8.2M | 6.2M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.94 | 1.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $885,400.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 66.18 |
| 52 Week Low | $0.81 | $0.38 |
| 52 Week High | $3.19 | $9.45 |
| Indicator | AKBA | NUAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 60.07 |
| Support Level | $0.84 | $3.89 |
| Resistance Level | $0.96 | $6.37 |
| Average True Range (ATR) | 0.06 | 0.48 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 52.22 | 65.48 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.